SUMMARY Parvovirus B19 (B19V) and human bocavirus 1 (HBoV1), members of the large
Parvoviridae family, are human pathogens responsible for a variety of diseases. For B19V in …

SUMMARY Parvovirus B19 (B19) was discovered in 1974 and is the only member of the
family Parvoviridae known to be pathogenic in humans. Despite the inability to propagate …

Parvovirus B19 is a significant human pathogen that causes a wide spectrum of clinical
complications ranging from mild, self‐limiting erythema infectiosum in immunocompetent …

This review includes the congenital infections best known by the acronym TORCH
(Toxoplasma gondii, rubella virus, cytomegalovirus, and herpes virus), as well as Zika virus …

Parvovirus B19 infects 1 to 5% of pregnant women, generally with normal pregnancy
outcomes. During epidemics, the rate of infection is higher. Major congenital anomalies …

Parvovirus B19 is a widespread infection that may affects 1–5% of pregnant women, mainly
with normal pregnancy outcome. The prevalence of infection is higher during epidemics …

The third edition of this established reference is the product of the combined efforts of many
professionals–obstetricians, pediatric cardiologists, sonographers, molecular biologists, and …

Objectives This guideline reviews the evidence relating to the effects of parvovirus B19 on
the pregnant woman and fetus, and discusses the management of women who are exposed …

Parvovirus B19 infection during pregnancy causes up to 27% cases of non‐immune hydrops
in anatomically normal fetuses. The virus is believed to cause arrest of maturation of red …

OBJECTIVES: to clarify the approximation of the frequency of B19-related nonimmune
hydrops fetalis (NIHF), and to know the critical period during which maternal infection led to …